-transparent.png){kind=logo}
In order to study their effects on the bile secretion, cyclosporine and methylprednisolone were injected intravenously into rats at a dose of 10 mg/kg b.w. for 30 min. Methylprednisolone had no effect on bile secretion. Cyclosporine led to transient intrahepatic cholestasis characterized by decreased bile flow as well as a decrease of bile salts and cholesterol in bile. Phospholipid levels were not affected. Liver biopsy showed no particular anomaly. These findings suggest that the observed cholestatic reaction may be due to impairment of the metabolism of cholesterol into bile salts or of the conjugation of bile salts rather than to disturbances in bile secretion. After liver transplantation in humans, cholestasis associated with acute rejection or nonspecific cholestasis cannot be attributed directly to the effect of cyclosporine. Cholestasis can be offset by administering taurocholate at a dose of 10 mumol/min/kg b.w. in order to maintain bile salt and phospholipid levels high enough to ensure proper "vectorization" of cholesterol to bile.
F Chanussot, and
D Botta-Fridlund, and
P Lechene de la Porte, and
V Sbarra, and
H Portugal, and
A M Pauli, and
J Hauton, and
A Gauthier, and
H Lafont
January 1986,
American journal of surgery,
F Chanussot, and
D Botta-Fridlund, and
P Lechene de la Porte, and
V Sbarra, and
H Portugal, and
A M Pauli, and
J Hauton, and
A Gauthier, and
H Lafont
January 1990,
Canadian journal of physiology and pharmacology,
F Chanussot, and
D Botta-Fridlund, and
P Lechene de la Porte, and
V Sbarra, and
H Portugal, and
A M Pauli, and
J Hauton, and
A Gauthier, and
H Lafont
January 1969,
Yonsei medical journal,
F Chanussot, and
D Botta-Fridlund, and
P Lechene de la Porte, and
V Sbarra, and
H Portugal, and
A M Pauli, and
J Hauton, and
A Gauthier, and
H Lafont
October 1988,
Transplantation,
F Chanussot, and
D Botta-Fridlund, and
P Lechene de la Porte, and
V Sbarra, and
H Portugal, and
A M Pauli, and
J Hauton, and
A Gauthier, and
H Lafont
July 1984,
The Journal of laboratory and clinical medicine,
F Chanussot, and
D Botta-Fridlund, and
P Lechene de la Porte, and
V Sbarra, and
H Portugal, and
A M Pauli, and
J Hauton, and
A Gauthier, and
H Lafont
April 1968,
Lille medical : journal de la Faculte de medecine et de pharmacie de l'Universite de Lille,
F Chanussot, and
D Botta-Fridlund, and
P Lechene de la Porte, and
V Sbarra, and
H Portugal, and
A M Pauli, and
J Hauton, and
A Gauthier, and
H Lafont
January 1997,
Transplantation,
F Chanussot, and
D Botta-Fridlund, and
P Lechene de la Porte, and
V Sbarra, and
H Portugal, and
A M Pauli, and
J Hauton, and
A Gauthier, and
H Lafont
February 1992,
Gastroenterology,
F Chanussot, and
D Botta-Fridlund, and
P Lechene de la Porte, and
V Sbarra, and
H Portugal, and
A M Pauli, and
J Hauton, and
A Gauthier, and
H Lafont
June 1978,
The American journal of physiology,
F Chanussot, and
D Botta-Fridlund, and
P Lechene de la Porte, and
V Sbarra, and
H Portugal, and
A M Pauli, and
J Hauton, and
A Gauthier, and
H Lafont
August 1973,
The Journal of laboratory and clinical medicine,
